Copyright
©The Author(s) 2019.
World J Gastroenterol. Sep 28, 2019; 25(36): 5483-5493
Published online Sep 28, 2019. doi: 10.3748/wjg.v25.i36.5483
Published online Sep 28, 2019. doi: 10.3748/wjg.v25.i36.5483
Figure 5 Sodium aescinate inhibits CARMA3/nuclear factor kappa-B signaling.
A and B: Expression of CARMA3 and NF-kB (p65) detected in HCC cells after treatment with sodium aescinate (SA) by immunofluorescence (magnification, ×400); C: Cell viability of high CARMA3 expressing hepatocellular carcinoma (HCC) cells and control HCC cells either treated with SA or saline. (bP < 0.01, cP < 0.001 vs control).
- Citation: Hou H, Li WX, Cui X, Zhou DC, Zhang B, Geng XP. CARMA3/NF-κB signaling contributes to tumorigenesis of hepatocellular carcinoma and is inhibited by sodium aescinate. World J Gastroenterol 2019; 25(36): 5483-5493
- URL: https://www.wjgnet.com/1007-9327/full/v25/i36/5483.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i36.5483